Mismatch Repair Deficient or MSI-High Solid Tumors trials recruiting in New Jersey

Fewer than 3 recruiting trials found.

All Mismatch Repair Deficient or MSI-High Solid Tumors trials nationally

Cities in New Jersey

Recruiting trials in New Jersey

• EIK1005-002: A Clinical Research Study Evaluating EIK1005, a Werner Helicase Inhibitor, as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors Including Microsatellite Instability High (MSI-H) Tumors
  NCT07262619 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · New Jersey: Morristown